WallStreetZenWallStreetZen

NASDAQ: GLSI
Greenwich Lifesciences Inc Stock

$15.50-0.77 (-4.73%)
Updated Jun 24, 2024
GLSI Price
$15.50
Fair Value Price
$0.54
Market Cap
$199.64M
52 Week Low
$7.58
52 Week High
$21.44
P/E
-21.53x
P/B
38.99x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$9.24M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.08
Operating Cash Flow
-$7M
Beta
0.41
Next Earnings
Aug 21, 2024
Ex-Dividend
N/A
Next Dividend
N/A

GLSI Overview

Greenwich LifeSciences, Inc. is a clinical stage biopharmaceutical company developing novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Known as Norwell, Inc. until 2018, Greenwich LifeSciences was incorporated in 2006 and is headquartered in Stafford, TX.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GLSI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GLSI ($15.50) is overvalued by 2,749.26% relative to our estimate of its Fair Value price of $0.54 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
GLSI ($15.50) is not significantly undervalued (2,749.26%) relative to our estimate of its Fair Value price of $0.54 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
GLSI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more GLSI due diligence checks available for Premium users.

Be the first to know about important GLSI news, forecast changes, insider trades & much more!

GLSI News

Valuation

GLSI fair value

Fair Value of GLSI stock based on Discounted Cash Flow (DCF)
Price
$15.50
Fair Value
$0.54
Overvalued by
2,749.26%
GLSI ($15.50) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GLSI ($15.50) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GLSI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

GLSI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-21.53x
Industry
-6.96x
Market
30.03x

GLSI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
38.99x
Industry
6.29x
GLSI is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GLSI's financial health

Profit margin

Revenue
$0.0
Net Income
-$2.5M
Profit Margin
0%
GLSI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$5.5M
Liabilities
$389.6k
Debt to equity
0.08
GLSI's short-term assets ($5.51M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GLSI's short-term assets ($5.51M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GLSI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$1.8M
Investing
$0.0
Financing
$299.1k
GLSI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

GLSI vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
GLSI$199.64M-4.73%-21.53x38.99x
BMEA$199.49M+5.51%-1.55x1.47x
TSVT$198.42M+3.76%-0.89x0.96x
GNFT$195.85M+1.29%-6.24x2.65x
ALDX$195.47M-5.46%-6.45x1.72x

Greenwich Lifesciences Stock FAQ

What is Greenwich Lifesciences's quote symbol?

(NASDAQ: GLSI) Greenwich Lifesciences trades on the NASDAQ under the ticker symbol GLSI. Greenwich Lifesciences stock quotes can also be displayed as NASDAQ: GLSI.

If you're new to stock investing, here's how to buy Greenwich Lifesciences stock.

What is the 52 week high and low for Greenwich Lifesciences (NASDAQ: GLSI)?

(NASDAQ: GLSI) Greenwich Lifesciences's 52-week high was $21.44, and its 52-week low was $7.58. It is currently -27.71% from its 52-week high and 104.49% from its 52-week low.

How much is Greenwich Lifesciences stock worth today?

(NASDAQ: GLSI) Greenwich Lifesciences currently has 12,879,995 outstanding shares. With Greenwich Lifesciences stock trading at $15.50 per share, the total value of Greenwich Lifesciences stock (market capitalization) is $199.64M.

Greenwich Lifesciences stock was originally listed at a price of $5.00 in Sep 25, 2020. If you had invested in Greenwich Lifesciences stock at $5.00, your return over the last 3 years would have been 210%, for an annualized return of 45.81% (not including any dividends or dividend reinvestments).

How much is Greenwich Lifesciences's stock price per share?

(NASDAQ: GLSI) Greenwich Lifesciences stock price per share is $15.50 today (as of Jun 24, 2024).

What is Greenwich Lifesciences's Market Cap?

(NASDAQ: GLSI) Greenwich Lifesciences's market cap is $199.64M, as of Jun 25, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Greenwich Lifesciences's market cap is calculated by multiplying GLSI's current stock price of $15.50 by GLSI's total outstanding shares of 12,879,995.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.